Reduction and methylation of ziprasidone by glutathione, aldehyde oxidase, and thiol s-methyltransferase in humans: an in vitro study

References

• Beedham C, Bruce SE, Critchley DJ, al-Tayib Y, Rance DJ. (1987). Species variation in hepatic aldehyde oxidase activity. Eur J Drug Metab Pharmacokinet 12:307–310.
   PubMed Web of Science ®Google Scholar
• Beedham C. (2002). Molybdenum hydroxylases. In: Ioannides C, ed. Enzyme Systems that Metabolise Drugs and Other Xenobiotics. Chichester, UK: John Wiley & Sons, 147–187.
   Google Scholar
• Beedham C, Miceli JJ, Obach RS. (2003). Ziprasidone metabolism, aldehyde oxidase, and clinical implications. J Clin Psychopharmacol 23:229–232.
   PubMed Web of Science ®Google Scholar
• Beutler E, Gelbart T.. (1985). Plasma glutathione in health and in patients with malignant disease. J Lab Clin Med 105:581–584.
   PubMed Web of Science ®Google Scholar
• Clarke SE, Harrell AW, Chenery RJ. (1995). Role of aldehyde oxidase in the in vitro conversion of famciclovir to penciclovir in human liver. Drug Metab Dispos 23:251–254.
   PubMed Web of Science ®Google Scholar
• Garattini E, Terao M. (2012). The role of aldehyde oxidase in drug metabolism. Expert Opin Drug Metab Toxicol 8:487–503.
   PubMed Web of Science ®Google Scholar
• Glauser TA, Nelson AN, Zembower DE, Lipsky JJ, Weinshilboum RM. (1993). Diethyldithiocarbamate S-methylation: evidence for catalysis by human liver thiol methyltransferase and thiopurine methyltransferase. J Pharmacol Exp Ther 266:23–32.
   PubMedGoogle Scholar
• Herzenberg L, De Rosa SC, Dubs JG, Roederer M, Anderson MT, Ela SW, Deresinski SC, Herzenberg LA.. (1997). Glutathione deficiency is associated with impaired survival in HIV disease. Proc Nat Acad Sci 94:1967–1972.
   PubMed Web of Science ®Google Scholar
• Houseknecht KL, Robertson AS, Zavadoski W, Gibbs EM, Johnson DE, Rollema H. (2007). Acute effects of atypical antipsychotics on whole-body insulin resistance in rats: implications for adverse metabolic effects. Neuropsychopharmacology 32:289–297.
   PubMed Web of Science ®Google Scholar
• Kitamura S, Ohashi KNK, Sugihara K, Hosokawa R, Akagawa Y, Ohta S. (2001). Extremely high drug-reductase activity based on aldehyde oxidase in monkey liver. Biol Pharm Bull 24:856–859.
   PubMed Web of Science ®Google Scholar
• Lauterburg BH, Velez ME.. (1988). Glutathione deficiency in alcoholics: risk factor for paracetamol hepatotoxicity. Gut 29:1153–1157.
   PubMed Web of Science ®Google Scholar
• Miao Z, Kamel A, Prakash C. (2005). Characterization of a novel metabolite intermediate of ziprasidone in hepatic cytosolic fractions of rat, dog, and human by ESI-MS/MS, hydrogen/deuterium exchange, and chemical derivatization. Drug Metab Dispos 33:879–883.
   PubMed Web of Science ®Google Scholar
• Miceli JJ, Smith M, Robarge L, Morse T, Laurent A.. (2000). The effects of ketoconazole on ziprasidone pharmacokinetics - a placebo-controlled crossover study in healthy volunteers. Br J Clin Pharmacol 49:71S–76S.
   PubMed Web of Science ®Google Scholar
• Miceli JJ, Wilner KD, Swan SK, Tensfeldt TG. (2005). Pharmacokinetics, safety, and tolerability of intramuscular ziprasidone in healthy volunteers. J Clin Pharmacol 45:620–630.
   PubMed Web of Science ®Google Scholar
• Obach RS, Huynh P, Allen MC, Beedham C. (2004). Human liver aldehyde oxidase: inhibition by 239 drugs. J Clin Pharmacol 44:7–19.
   PubMed Web of Science ®Google Scholar
• Obach RS, Walsky RL. (2005). Drugs that inhibit oxidation reactions catalyzed by aldehyde oxidase do not inhibit the reductive metabolism of ziprasidone to its major metabolite, S-methyldihydroziprasidone: an in vitro study. J Clin Psychopharmacol 25:605–608.
   PubMed Web of Science ®Google Scholar
• Prakash C, Kamel A, Gummerus J, Wilner K. (1997). Metabolism and excretion of a new antipsychotic drug, ziprasidone, in humans. Drug Metab Dispos 25:863–872.
   PubMed Web of Science ®Google Scholar
• Prakash C, Kamel A, Cui D, Whalen RD, Miceli JJ, Tweedie D. (2000). Identification of the major human liver cytochrome P450 isoform(s) responsible for the formation of the primary metabolites of ziprasidone and prediction of possible drug interactions. Br J Clin Pharmacol 49 Suppl 1:35S–42S.
   PubMed Web of Science ®Google Scholar
• Pryde DC, Dalvie D, Hu Q, Jones P, Obach RS, Tran TD. (2010). Aldehyde oxidase: an enzyme of emerging importance in drug discovery. J Med Chem 53:8441–8460.
   PubMed Web of Science ®Google Scholar
• Reynolds GP, Kirk SL. (2010). Metabolic side effects of antipsychotic drug treatment–pharmacological mechanisms. Pharmacol Ther 125:169–179.
   PubMed Web of Science ®Google Scholar
• Schmidt AW, Lebel LA, Howard HR Jr, Zorn SH. (2001). Ziprasidone: a novel antipsychotic agent with a unique human receptor binding profile. Eur J Pharmacol 425:197–201.
   PubMed Web of Science ®Google Scholar
• Schofield PC, Robertson IG, Paxton JW. (2000). Inter-species variation in the metabolism and inhibition of N-[(2′-dimethylamino)ethyl]acridine-4-carboxamide (DACA) by aldehyde oxidase. Biochem Pharmacol 59:161–165.
   PubMed Web of Science ®Google Scholar
• Seeff LB, Cuccherini BA, Zimmerman HJ, Adler E, Benjamin SB.. (1986). Acetaminophen hepatotoxicity in alcoholics. A therapeutic misadventure. Ann Int Med 104:399–404.
   PubMed Web of Science ®Google Scholar
• Stimmel GL, Gutierrez MA, Lee V. (2002). Ziprasidone: an atypical antipsychotic drug for the treatment of schizophrenia. Clin Ther 24:21–37.
   PubMed Web of Science ®Google Scholar
• Sugihara K, Kitamura S, Tatsumi K. (1996). Involvement of mammalian liver cytosols and aldehyde oxidase in reductive metabolism of zonisamide. Drug Metab Dispos 24:199–202.
   PubMed Web of Science ®Google Scholar
• Trenti T, Bertolotti M, Castellana CN, Ferrari A, Pini LA, Sternieri E.. (1992). Plasma glutathione level in paracetamol daily abuser patients. Changes in plasma cysteine and thiol groups after reduced glutathione administration. Toxicol Lett 64–65:757–761.
   Web of Science ®Google Scholar
• Vijayamalini M, Manoharan S. (2004). Lipid peroxidation, vitamins C, E and reduced glutathione levels in patients with pulmonary tuberculosis. Cell Biochem Funct 22:19–22.
   PubMed Web of Science ®Google Scholar